Abstract. The aim was to compare the three molecular forms of plasma immunoreactive gastric inhibitory polypeptide (IR-GIP) 
IR-GIP, found in type 1 diabetics with those found in normal subjects. Plasma from 6 non-fasting newly diagnosed ketotic type 1 diabetics obtained before and 1 h after a test meal given at start of insulin treatment, and before and 1 h after a test meal given after one and seven days of insulin treatment, respectively, was gel filtered and so was plasma from 6 normal subjects. The (Krarup et al. 1983 ) and recovery of 8 kDa IR-GIP has been estimated to be of a similar magnitude (Krarup et al. 1985a (Heding 1972 ). Plasma C-peptide was measured by the method of Heding (1975) using the antiserum M 1230 (Faber et al. 1976 Gel filtration profiles for 2 diabetics and 2 normal subjects determined with the antisera RIC34IIIf, GIP19 and S100. See legend to Fig. 1 . Blood glucose (BG), insulin (IRI), and C-peptide (CP) concentrations before and after the respective meals in 6 type 1 diabetics (IDD) and 6 normal subjects (NS The IR-GIP concentrations were somewhat, al¬ though insignificantly, higher in the diabetics 1 h after the meal on the first day than the corres¬ ponding value in the normal subjects. This can be explained by the higher than fasting preprandial IR-GIP levels, since the increments of both 8 and 5 kDa IR-GIP were similar in diabetic and normal subjects. Creutzfeldt & Ebert (1977) found no significant IR-GIP response to a 1031-cal stan¬ dard meal in ketotic juvenile diabetics. This may be due to the very high IR-GIP levels measured in these patients before the meal.
The present study largely confirms the previ¬ ously described differences between the antisera in cross-reactivity with the IR-GIP components (Krarup & Hoist 1984; Krarup et al. 1985a ). As discussed in detail (Krarup et al. 1985a) (Krarup et al. 1983) . In that study 15 type 1 diabetics were examined and although the responses were significantly lower, an overlap with those of the normal subjects was observed, which may explain that no difference was found in this study with fewer patients.
No significant difference in V0 between diabetic and normal subjects was found and no increase in void volume immunoreactivity after the meals was observed. There was, however, a tendency for a decreasing level of the V0 immunoreactivity after start of insulin treatment in the diabetics to levels (10-15 pmol/1) also previously measured in nor¬ mal subjects with GÖ5/76/9 and R65 (Krarup et al. 1985a ). Whether the decrease was caused by the insulin treatment, by an effect of dilution when the patients were rehydrated, or by some other mechanism is unknown. Although only slightly, V0-IR-GIP, therefore, may be elevated during ketosis.
Brown et al. (1979) suggested that V0-IR-GIP represents a complex formed by the non-specific binding of GIP to a serum protein. The unusually high recoveries of GIP after gel filtration of human serum samples Krarup et al. 1983) could support this suggestion. How¬ ever, the lack of an increase in V0-IR-GIP after a meal and after glucose and fat (Krarup et al. 1985a ) and the fact that the amount of V0-IR-GIP does not vary according to the cross-reactivity with 5 and 8 kDa IR-GIP described for the differ¬ ent antisera (Krarup et al. 1985a ) make the sug¬ gestion less likely. Gastrin immunoreactivity eluting in the void volume (big big gastrins) has previously been found attributable to interference in the gastrin assay by normal serum proteins or, to a limited extent to non-covalent protein-bind¬ ing of smaller gastrins (Rehfeld et al. 1977 
